The function of the recently discovered angiotensin II type 2 (AT2) receptor remains elusive. This receptor is expressed abundantly in fetus, but scantily in adult tissues except brain, adrenal medulla, and atretic ovary. In this study, we demonstrated that this receptor mediates programmed cell death (apoptosis). We observed this effect in PC12W cells (rat pheochromocytoma cell line) and R3T3 cells (mouse fibroblast cell line), which express abundant AT2 receptor but not AT1 receptor. The cellular mechanism appears to involve the dephosphorylation of mitogen-activated protein kinase (MAP kinase (3, 4) which is abundantly expressed in fetal tissues and immature brain (5) but present only at low levels in certain adult tissues (6-8). Recently, we and others have reported that the AT2 receptor mediates anti-growth effects on vascular smooth muscle (9) and endothelial (10) cells. To examine further the mechanism of the anti-growth action of the AT2 receptor, we studied its effect on programmed cell death (apoptosis). We also elucidated the biochemical signal transduction mechanism of the AT2 receptor mediating apoptosis.
Angiotensin II (Ang II) exerts via the type 1 (AT1) receptor diverse actions on its target tissues controlling vascular tone, hormone secretion, tissue growth, and neuronal activities (1, 2) . However, little is known about physiological function(s) of the type 2 (AT2) receptor (3, 4) which is abundantly expressed in fetal tissues and immature brain (5) but present only at low levels in certain adult tissues (6) (7) (8) . Recently, we and others have reported that the AT2 receptor mediates anti-growth effects on vascular smooth muscle (9) and endothelial (10) cells. To examine further the mechanism of the anti-growth action of the AT2 receptor, we studied its effect on programmed cell death (apoptosis). We also elucidated the biochemical signal transduction mechanism of the AT2 receptor mediating apoptosis.
We first studied PC12W cells, a subline of the PC12 rat pheochromocytoma cell line (11) , which express high levels of the AT2 but not the AT1 receptor. These cells differentiate into neuronal-like cells in the presence of nerve growth factor (NGF) and provide a good model for investigating programmed neural cell death (12) . Second we studied R3T3 cells, a mouse fibroblast cell line whose expression of AT2 receptor is modulated by the growth state of the cells-i.e., very low in actively growing cells but increasing markedly in the confluent, quiescent state (13) . This cell line is a good model for studying the growth-regulatory function of AT2 receptor.
MATERIALS AND METHODS
Cells and Treatment. PC12W cells were grown and underwent differentiation in Dulbecco's modified Eagle's medium (DMEM) (GIBCO) plus 10% horse serum, 5% fetal bovine serum (FBS), and NGF (10 ng/ml). R3T3 cells were maintained in DMEM plus 10% FBS.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (17) . Oligonucleotide sequences (20 nt) were as follows (17): MKP-1 antisense, 5'-GGAACTCAGTGGAACTCAGG-3'; MKP-1 sense, 5'-CCTGAGTTCCACTGAGTTCC-3'. The cells were maintained in the presence of serum and NGF (10 ng/ml) for 2 days. Then the medium was changed to serumfree medium containing NGF (1 ng/ml) with or without Ang II. Two days later, cells were harvested and DNA fragmentation was studied. MKP-1 antisense-transfected PC12W cells were also used for measurement of MAP kinase activity as described above.
Statistics. Statistical analysis was performed by ANOVA, followed by Scheffe's test. P < 0.05 was considered significant. Data are expressed as mean ± SE.
RESULTS AND DISCUSSION
Upon serum or NGF starvation, PC12W cells underwent morphological changes typical of apoptosis, in a manner similar to that reported by Pittman et al. (12) The nucleus became condensed (Fig. 1C ) 24 hr after serum removal and fragmented or marginated thereafter ( Fig. 1 D  and E) . The cells shrank in size and the membrane developed ruffle and blebs. NGF inhibited these apoptotic processes. To evaluate the effect of Ang II on apoptosis induced by NGF removal in PC12W cells, we first maintained cells in DMEM containing 10% horse serum, 5% FBS, and NGF (10 ng/ml) for 1 week and then changed to serum-free medium supplemented with a minimal level of NGF (1 ng/ml) that blocked apoptosis (Fig. 1A) . Under this condition, we observed that Ang II (0.1 ,uM) induced apoptotic morphological changes (Fig. 1B) . To examine whether Ang II could override the antiapoptotic effect of NGF, we treated serum-starved PC12W cells with Ang II in the presence of NGF at 1 ng/ml and observed that the addition of Ang 11 (0.1 ,tM) for 48 hr induced marked fragmentation of DNA into multiples of -180 bp (the size of a nucleosome) in a dose-dependent manner ( Fig. 2A) . This enhancing effect of Ang II on the DNA fragmentation was blocked by PD123319 (10 ,tM), a selective AT2 receptor antagonist but not by Dup753 (10 ,uM), a selective AT1 receptor antagonist, demonstrating that enhanced apoptosis was mediated via the AT2 receptor in PC12W cells (Fig. 2B) . Interestingly, AT2 receptor expression in PC12W cells was upregulated by serum removal and NGF withdrawal but was downregulated by the addition of NGF (Fig. 3A) , suggesting that AT2 receptor expression was closely related to the apoptotic events. The fraction of cells undergoing apoptosis is shown in Fig. 3B .
To examine whether this effect could be observed in other no drug (mean + SE, n = 4 for each condition). the growing phase (13) . Serum starvation caused DNA fragmentation in both growing and confluent R3T3 cells. The addition of Ang 11 (0.1 ,M) further enhanced DNA fragmentation in the confluent R3T3 cells, but not in the growing cells (Fig. 4) . This effect was blocked by PD123319 (10 ,uM) . Serum depletion induced AT2 receptor expression in confluent R3T3 cells but not in growing R3T3 cells (data not shown).
The intracellular signal transduction mechanism that follows the activation of AT2 receptor is not well defined. Activation of the Ras and MAP kinase pathway has been reported to be necessary and sufficient for cell differentiation or proliferation in PC12 cells in response to NGF (18) . We focused on the effect of AT2 receptor on NGF-stimulated MAP kinase activity. NGF stimulated the MAP kinase activity of PC12W cells in a dose-dependent fashion. This was attenuated by Ang II in a dose-dependent manner and this effect of Ang 11 (0.1 AM) was abolished by PD123319 (10 ,M) (Fig. SA) 10 5 Proc. Natl. Acad. Sci. USA 93 (1996) protein-tyrosine-phosphatase (PTPase) inhibitor, 10 ,xM] and PTX (a Gi/G. protein inhibitor, 200 ng/ml) also abolished this effect. However, okadaic acid (a protein-serine/threoninephosphatase inhibitor, 0.1 ,uM) did not (Fig. SB) . Ang II also attenuated serum-stimulated MAP kinase in the confluent R3T3 cells but not in the growing R3T3 cells (data not shown).
MAP kinases are protein-serine/threonine kinases and their activity is rapidly decreased by dephosphorylation of Tyr-185, emphasizing the importance of PTPase in regulating MAP kinase activity. We hypothesize that AT2 receptor dephosphorylates MAP kinase, resulting in the inactivation of NGFstimulated MAP kinase. MAP kinase dephosphorylation induced by Ang II reached a maximum 5 min after treatment (Fig. 6A) and Ang II induced dephosphorylation of MAP kinase in a dose-dependent manner (Fig. 6B ) in PC12W cells. The MAP kinase dephosphorylation by Ang 11 (0.1 ,M) was blocked by pretreatment of cells with PD123319 (10 ,M), vanadate (10 ,uM), or PTX (200 ng/ml) (data not shown), suggesting that this MAP kinase dephosphorylation is AT2 receptor-specific and at least partially due to the activation of G protein and PTPase.
Next we examined the direct effect of vanadate and PTX on the AT2 receptor-mediated apoptosis. Vanadate or PTX attenuated the AT2 receptor-mediated apoptotic changes (Fig.  7) . However, okadaic acid did not show any effect. These results demonstrate that a G-protein coupling mechanism participates in the induction of AT2 receptor-mediated apoptosis in PC12W cells.
A PTPase, MAP kinase phosphatase 1 (MKP-1), has been shown to selectively dephosphorylate tyrosine-phosphorylated MAP kinase (19) and is known to be involved in cell growth (17, 19) . We transfected PC12W cells with antisense oligonucleotide against MKP-1 mRNA according to Duff et al. (17) and observed that this transfection increased the NGFstimulated MAP kinase activity and blocked the Ang IIinduced MAP kinase inactivation (Fig. 8A) . Sense oligonucleotide-transfected or vehicle-transfected PC12W cells exhibited marked apoptosis in response to Ang II (0.1 ,uM), whereas antisense oligonucleotide treatment blocked AT2 receptormediated apoptosis (Fig. 8B) . Thus, MKP-1 is involved in AT2 receptor-mediated apoptosis in PC12W cells.
Since the AT2 receptor is expressed in adrenal medulla (6), it is intriguing to speculate that this receptor may play a role in adrenal medullar apoptosis. However, the role of apoptosis in adrenal physiology is unclear. In the ovary, the granulosa cells of the atretic follicles that express high levels of AT2 receptors are known to undergo marked apoptosis (8, 14) . The role of AT2 receptor in the process of ovarian apoptosis remains to be defined. However, it is interesting to hypothesize that this receptor mediates ovarian atresia. The reexpression of AT2 receptor after vascular injury or myocardial infarction (20) and in skin wound healing (21) also suggests that the AT2 receptor is involved in the pathophysiology of these proliferative conditions. We also observed that overexpression of an AT2 receptor transgene in balloon-injured rat carotid artery reduced neointimal formation (9) . Indeed, a recent study also suggests that the AT2 receptor mediates an antigrowth effect in cultured endothelial cells (10) . Together, these data demonstrate that the AT2 receptor exerts a growth-inhibitory effect and that one of the antigrowth mechanisms is apoptosis.
